[1] Sinclair C,Gaunt E,Simmonds P,et al.Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014[J].Euro Surveill,2014,19(12):20745. [2] 龚晓辉,曾建武,段建平,等.湘潭地区2013-2014年手足口病病原监测结果分析[J].现代生物医学进展,2015,15(30):5907-5909. [3] 苏明,倪祥文,李娟娟,等.保定市EV71和CoxA6、10、16型所致手足口病病原学分析[J].实用预防医学,2015,22(2):239-241. [4] Mao QY,Wang Y,Bian L,et al.EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)[J].Expert Rev Vaccines,2016,15(5):599-606. [5] 林春燕,王明昌,曾小平,等.海口市2008-2015年手足口病流行病学特征分析[J].中华流行病学杂志,2016,37(12):1615-1618. [6] 卫生部.手足口病预防控制指南(2009版)[J].全科医学临床与教育,2010,8(2):125-127,133. [7] 中华人民共和国卫生部.手足口病诊疗指南(2010年版)[J].国际呼吸杂志,2010,30(24):1473-1475. [8] 王春荣,关恒云,韩秀云,等.2009-2013年济南地区重症手足口病病原学及流行病学分析[J].实用预防医学,2015,22(1):60-62. [9] Chen M,Ju Y,Chen M,et al.Epidemiological and genetic characteristics of EV71 in hand, foot, and mouth disease in Guangxi, southern China, from 2010 to 2015[J].PLoS One,2017,12(12):e0188640. [10] 张维,李娜,李侗曾,等.肠道病毒71型与非肠道病毒71感染所致的合并神经系统损害手足口病的对比分析[J].广西医学,2017,39(8):1178-1181. [11] Wei M,Meng F,Wang S,et al.2-Year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study[J].J Infect Dis,2017,215(1):56-63.
2018, Vol. 25 
